or Try an Advanced Search...

    Pharmaceuticals Segment Stocks List

    Symbol Grade Name % Change
    NVO B Novo Nordisk A/S 0.77
    PRGO F Perrigo Company -0.97
    XPH D SPDR S&P Pharmaceuticals ETF 0.26
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic
    Related Stock Lists: Diabetes Diabetes Care Hormones Pharmaceutical Products Active Pharmaceutical Ingredients Allergy Analgesics Animal Health Anti Diabetic Drugs Biopharmaceutical Cough Dietary Supplement ETF Endocrine System Exchange Traded Fund Feminine Hygiene Gastrointestinal Generic Drug Glucagon Like Peptide 1 Growth Hormone

    Related ETFs - A few ETFs which own one or more of the above listed Pharmaceuticals Segment stocks.

    Symbol Grade Name Weight
    EDEN A iShares MSCI Denmark Capped ETF 22.33
    PPH B Market Vectors Pharmaceutical ETF 10.12
    IGTR B Innovator Gradient Tactical Rotation Strategy ETF 8.56
    PJIO B PGIM Jennison International Opportunities ETF 7.63
    GK B AdvisorShares Gerber Kawasaki ETF 6.63
    View all Pharmaceuticals Segment ETFs...
    Compare ETFs
    Compare EDEN to PJIO Compare PPH to GK Compare PPH to IGTR

        Pharmaceuticals Segment Stocks Recent News

        Date Stock Title
        May 20 NVO Hims & Hers Stock Spikes. It’s Taking on Big Pharma With Cheap Obesity Shots.
        May 20 NVO Wellness Platform Hims & Hers Health Adds GLP-1 Injections For Weight Loss, Stock Soars
        May 20 NVO Genetics may determine who responds well to Wegovy: report
        May 20 NVO Genetic Profile Key To Novo Nordisk's Wegovy's Weight-Loss Effectiveness, Study Reveals
        May 20 NVO Hims & Hers surges on cheap compounded versions of Novo Nordisk's semaglutide
        May 20 NVO The Zacks Analyst Blog Highlights Stocks recently featured in the blog include: Novo Nordisk, Eli Lilly's, Viking, Altimmune, Roche and Amgen
        May 19 NVO SA Roundtable: Are Eli Lilly and Novo Nordisk overvalued?
        May 19 NVO Biopharma M&A surges year over year in Q1
        May 18 NVO Novo Nordisk, J&J lead R&D rankings in big pharma: report
        May 18 NVO Microsoft Leads Five Stocks Near Buy Points As Market Flashes Green
        May 18 NVO 3 Monster Stocks in the Making You Can Buy Right Now
        May 18 NVO Is Novo Nordisk Stock a Millionaire Maker?
        May 17 NVO 4 Stocks That Could Break Novo Nordisk, Lilly's Obesity Duopoly
        May 17 NVO Pharma Stock Roundup: BAYRY's Q1 Earnings, JNJ's New Buyout, Pipeline Updates
        May 17 NVO 4 Stocks That Could Break Novo Nordisk, Lilly's Obesity Duopoly
        May 17 NVO Novo Nordisk A/S (NVO) is Attracting Investor Attention: Here is What You Should Know
        May 17 NVO Meet the GLP-1 Drug That Could Be the Biggest Concern for Eli Lilly and Novo Nordisk
        May 16 NVO Dow Jones hits record milestone as US bets on faster rate cuts
        May 16 NVO Denmark enjoys ‘Nokia moment’ as Ozempic flies off the shelves
        May 16 NVO Ozempic drives economic boom in Denmark as growth forecasts doubled
        Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic
        Related Stock Lists: Diabetes Diabetes Care Hormones Pharmaceutical Products Active Pharmaceutical Ingredients Allergy Analgesics Animal Health Anti Diabetic Drugs Biopharmaceutical Cough Dietary Supplement ETF Endocrine System Exchange Traded Fund Feminine Hygiene Gastrointestinal Generic Drug Glucagon Like Peptide 1 Growth Hormone
        Pharmaceuticals Segment

        Pharmaceuticals segment is a sector of the healthcare industry that focuses on the research, development, production, and marketing of drugs and other pharmaceutical products. This segment includes companies that manufacture and distribute prescription and over-the-counter drugs, as well as those that provide related services such as contract manufacturing and clinical research.

        Browse All Tags